PLERIXAFOR

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C28H54N8
Molecular Weight	502.782
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of PLERIXAFOR

Structure Search

SMILES

C(N1CCCNCCNCCCNCC1)C2=CC=C(CN3CCCNCCNCCCNCC3)C=C2

InChI

InChIKey=YIQPUIGJQJDJOS-UHFFFAOYSA-N

InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2

HIDE SMILES / InChI

Molecular Formula	C28H54N8
Molecular Weight	502.782
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:15:52 UTC 2023` Edited by `admin` on `Fri Dec 15 16:15:52 UTC 2023`
Record UNII	S915P5499N
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PLERIXAFOR

Official Name

English

PLERIXAFOR [ORANGE BOOK]

Common Name

English

PLERIXAFOR [JAN]

Common Name

English

PLERIXAFOR [EMA EPAR]

Common Name

English

Plerixafor [WHO-DD]

Common Name

English

PLERIXAFOR [USAN]

Common Name

English

PLERIXAFOR [MART.]

Common Name

English

plerixafor [INN]

Common Name

English

PLERIXAFOR [VANDF]

Common Name

English

PLERIXAFOR [MI]

Common Name

English

1,1'-(1,4-PHENYLENEBIS(METHYLENE))BIS-1,4,8,11-TETRAAZACYCLOTETRADECANE

Systematic Name

English

1,4,8,11-TETRAAZACYCLOTETRADECANE, 1,1'-(1,4-PHENYLENEBIS(METHYLENE))BIS-

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

167903

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

FDA ORPHAN DRUG

346111

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

WHO-VATC

QL03AX16

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

EMA ASSESSMENT REPORTS

MOZOBIL (AUTHORIZED: HEMATOPOIETIC STEM CELL TRANSPLANTATION)

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

NDF-RT

N0000178324

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

WHO-ATC

L03AX16

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

EMA ASSESSMENT REPORTS

MOZOBIL (AUTHORIZED: LYMPHOMA)

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

EMA ASSESSMENT REPORTS

MOZOBIL (AUTHORIZED: MULTIPLE MYELOMA)

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

EU-Orphan Drug

EU/3/11/931

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

NDF-RT

N0000178326

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

NCI_THESAURUS

C63817

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

Code System Code Type Description

EVMPD

SUB28849

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

IUPHAR

844

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

PUBCHEM

65015

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

EPA CompTox

DTXSID70869520

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

RXCUI

733003

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

RxNorm

DRUG CENTRAL

4410

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

ChEMBL

CHEMBL18442

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

CAS

110078-46-1

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

DRUG BANK

DB06809

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

NCI_THESAURUS

C1777

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

DAILYMED

S915P5499N

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

CHEBI

125354

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

SMS_ID

100000092971

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

INN

8513

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

FDA UNII

S915P5499N

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

USAN

PP-79

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

WIKIPEDIA

PLERIXAFOR

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

MERCK INDEX

m8919

Created by admin on Fri Dec 15 16:15:52 UTC 2023 , Edited by admin on Fri Dec 15 16:15:52 UTC 2023

PRIMARY

Merck Index

Related Record Type Details


					S915P5499N

EXCRETED UNCHANGED

Interaction Type:

AMOUNT EXCRETED

Qualification:

URINE

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					OD49913540

PLERIXAFOR OCTAHYDROCHLORIDE

SALT/SOLVATE -> PARENT


					B5GGG91KI4

C-X-C CHEMOKINE RECEPTOR TYPE 4

TARGET -> INHIBITOR

Related Record Type Details


					39642MM938

1,8-BIS((4-(1,4,8,11-TETRAAZACYCLOTETRADEC-1-YLMETHYL)PHENYL)METHYL)-1,4,8,11-TETRAAZACYCLOTETRADECANE

IMPURITY -> PARENT

Amount:


					75HB2GJG5Q

1-((4-METHYLPHENYL)METHYL)-1,4,8,11-TETRAAZACYCLOTETRADECANE

IMPURITY -> PARENT

Amount:


					R5QH4G2ZBZ

N-(4-HYDROXYMETHYLBENZYL) CYCLAM

IMPURITY -> PARENT

Amount:

Related Record Type Details


					S915P5499N

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC

Tmax	PHARMACOKINETIC				SC DOSE

Volume of Distribution	PHARMACOKINETIC